Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications

被引:21
作者
Arasakumar, Thangaraj [1 ,2 ]
Mathusalini, Sadasivam [1 ]
Ata, Athar [2 ]
Shankar, Ramasamy [3 ]
Gopalan, Subashini [1 ]
Lakshmi, Krishnasamy [1 ,4 ]
Sakthivel, Pandiyarajan [4 ]
Mohan, Palathurai Subramaniam [1 ]
机构
[1] Bharathiar Univ, Sch Chem Sci, Coimbatore 641046, Tamil Nadu, India
[2] Univ Winnipeg, Dept Chem, Richardson Coll Environm Sci Complex, 599 Portage Ave, Winnipeg, MB R3B 2G3, Canada
[3] Bharathiar Univ, Dept Phys, Coimbatore 641046, Tamil Nadu, India
[4] Bharathiar Univ, DRDO BU CLS, Coimbatore 641046, Tamil Nadu, India
基金
加拿大自然科学与工程研究理事会;
关键词
Spiropyrrolidine; Quinolone; Multicomponent reaction; DFT calculation; Antibacterial activity; Cytotoxicity; MOLECULAR-ORBITAL METHODS; CATALYTIC ASYMMETRIC CONSTRUCTION; GAUSSIAN-TYPE BASIS; 1,3-DIPOLAR CYCLOADDITION; STRATEGIC APPROACH; BASIS-SET; ANTIBACTERIAL; CIPROFLOXACIN; ANTIMALARIAL; INHIBITORS;
D O I
10.1007/s11030-016-9695-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 4-quinolone-3-carboxylic acid-containing spirooxindole-pyrrolidine derivatives was synthesized via multicomponent 1,3-dipolar cycloaddition reactions of azomethine ylides with new (E)-4-oxo-6-(3-phenyl-acryloyl)-1,4-dihydroquinoline-3-carboxylic acids in good yields with high regioselectivity. The cycloadducts were characterized by analytical and spectral data including , , 2D NMR and mass spectroscopy. The structure of one of the compounds (8a) was investigated theoretically by computational techniques. DFT studies support the proposed mechanism for this cycloaddition reaction. Furthermore, antibacterial activities of the new compounds were evaluated against Gram-positive and Gram-negative bacterial strains. Compounds 8f, 8m and 8p showed potent inhibition activities against selected bacteria. The in vitro cytotoxicity of spirooxindole derivatives (8a-r) was evaluated against MCF-7 breast cancer cell line. Among the various compounds tested, compound 8f showed significant cytotoxic activity compared to the standard drug doxorubicin .
引用
收藏
页码:37 / 52
页数:16
相关论文
共 57 条
[1]   Synthesis of Intervenolin, an Antitumor Natural Quino lone with Unusual Substituents [J].
Abe, Hikaru ;
Kawada, Manabu ;
Inoue, Hiroyuki ;
Ohba, Shun-ichi ;
Nomoto, Akio ;
Watanabe, Takumi ;
Shibasaki, Masakatsu .
ORGANIC LETTERS, 2013, 15 (09) :2124-2127
[2]   A facile synthesis of novel pyridone-annelated spirooxindolepyrrolidines via 1,3-dipolar cycloaddition [J].
Al-As'ad, Randa M. ;
El-Abadelah, Mustafa M. ;
Sabri, Salim S. ;
Zahra, Jalal A. ;
Awwadi, Firas F. ;
Voelter, Wolfgang .
MONATSHEFTE FUR CHEMIE, 2015, 146 (04) :621-629
[3]   Mechanism of Quinolone Action and Resistance [J].
Aldred, Katie J. ;
Kerns, Robert J. ;
Osheroff, Neil .
BIOCHEMISTRY, 2014, 53 (10) :1565-1574
[4]   The quinolones: Past, present, and future [J].
Andriole, VT .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S113-S119
[5]  
[Anonymous], 1964, MOL ORBITALS CHEM PH
[6]   Synthesis of benzoxepinopyrrolidines/spiropyrrolidines via oxa-Pictet-Spengler and [3+2] cycloaddition reactions [J].
Bakthadoss, Manickam ;
Sivakumar, Nagappan ;
Devaraj, Anthonisamy .
TETRAHEDRON LETTERS, 2015, 56 (35) :4980-4983
[7]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[8]   Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story" [J].
Bisacchi, Gregory S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) :4874-4882
[9]   A strategic approach to the synthesis of novel class of dispiroheterocyclic derivatives through 1,3 dipolar cycloaddition of azomethine ylide with (E)-3-arylidene-2,3-dihydro-8-nitro-4-quinolone [J].
Chandraprakash, Kumarasamy ;
Sankaran, Mathan ;
Uvarani, Chokalingam ;
Shankar, Ramasamy ;
Ata, Athar ;
Dallemer, Frederic ;
Mohan, Palathurai Subramaniam .
TETRAHEDRON LETTERS, 2013, 54 (29) :3896-3901
[10]  
Clinical and Laboratory Standard Institute, 2008, M45A CLIN LAB STAND